Health care companies in the United States by one-year price change
How far the share price has moved over the last 52 weeks.
Moderna leads the 140 health care companies in the United States ranked by one-year price change, at +740%, ahead of Erasca (+387%) and Kodiak Sciences (+371%). Figures as of 21 Nov 2026, 06:02 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 140
- First
- Moderna+740%
- Median
- +22.1%
- Combined market value
- SGD 9.42T
- Countries
- 1
Market values as of .
United States▾
Health Care▾
All categories▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ModernaMRNA · Health Care | +740% | SGD 101.8B | SGD 251.55 | 2.17% down | 740% up | ||
| 2 | ErascaERAS · Health Care | +387% | SGD 6.2B | SGD 17.56 | 4.29% down | 387% up | ||
| 3 | Kodiak SciencesKOD · Health Care | +371% | SGD 8.2B | SGD 125.35 | 0.75% down | 371% up | ||
| 4 | Spyre TherapeuticsSYRE · Health Care | +302% | SGD 11.5B | SGD 120.58 | 4.26% down | 302% up | ||
| 5 | Twist BioscienceTWST · Health Care | +291% | SGD 9.1B | SGD 133.28 | 7.44% down | 291% up | ||
| 6 | Oruka TherapeuticsORKA · Health Care | +233% | SGD 8.4B | SGD 123.59 | 1.80% down | 233% up | ||
| 7 | VeradermicsMANE · Health Care | +230% | SGD 6.5B | SGD 154.18 | 3.92% down | 230% up | ||
| 8 | ImmunityBioIBRX · Health Care | +216% | SGD 8.3B | SGD 7.77 | 8.37% down | 216% up | ||
| 9 | 10x GenomicsTXG · Health Care | +213% | SGD 8.8B | SGD 66.82 | 9.72% down | 213% up | ||
| 10 | Definium TherapeuticsDFTX · Health Care | +176% | SGD 5B | SGD 36.56 | 3.87% down | 176% up | ||
| 11 | GlaukosGKOS · Health Care | +139% | SGD 18.1B | SGD 306.13 | 0.33% down | 139% up | ||
| 12 | Revolution MedicinesRVMD · Health Care | +125% | SGD 45B | SGD 207.95 | 1.11% up | 125% up | ||
| 13 | LifeStance Health GroupLFST · Health Care | +107% | SGD 6.8B | SGD 17.83 | 3.60% up | 107% up | ||
| 14 | Concentra Group Holdings ParentCON · Health Care | +105% | SGD 6.8B | SGD 53.97 | 0.94% up | 105% up | ||
| 15 | Dianthus TherapeuticsDNTH · Health Care | +105% | SGD 6.1B | SGD 109.07 | 0.33% down | 105% up | ||
| 16 | TG TherapeuticsTGTX · Health Care | +103% | SGD 12.4B | SGD 81.71 | 2.37% down | 103% up | ||
| 17 | Charles River Laboratories InternationalCRL · Health Care | +95.6% | SGD 19.4B | SGD 405.47 | 4.15% down | 96% up | ||
| 18 | Oscar HealthOSCR · Health Care | +94.1% | SGD 9.9B | SGD 31.90 | 5.50% down | 94% up | ||
| 19 | CG OncologyCGON · Health Care | +93.0% | SGD 9.2B | SGD 102.52 | 2.97% down | 93% up | ||
| 20 | ViatrisVTRS · Health Care | +90.1% | SGD 29B | SGD 25.32 | 1.26% down | 90% up | ||
| 21 | BrightSpring Health ServicesBTSG · Health Care | +85.1% | SGD 16.1B | SGD 81.13 | 1.77% down | 85% up | ||
| 22 | Praxis Precision MedicinesPRAX · Health Care | +83.1% | SGD 10.8B | SGD 387.55 | 3.37% down | 83% up | ||
| 23 | Lantheus HoldingsLNTH · Health Care | +82.9% | SGD 8.6B | SGD 131.71 | 0.00% | 83% up | ||
| 24 | Edgewise TherapeuticsEWTX · Health Care | +81.6% | SGD 5.6B | SGD 51.48 | 3.07% down | 82% up | ||
| 25 | Kymera TherapeuticsKYMR · Health Care | +80.8% | SGD 12.7B | SGD 148.75 | 3.42% down | 81% up | ||
| 26 | CenteneCNC · Health Care | +79.7% | SGD 40.7B | SGD 82.28 | 2.74% down | 80% up | ||
| 27 | Amneal PharmaceuticalsAMRX · Health Care | +79.0% | SGD 9.5B | SGD 27.24 | 1.26% down | 79% up | ||
| 28 | Royalty PharmaRPRX · Health Care | +74.0% | SGD 50.8B | SGD 88.30 | 1.08% up | 74% up | ||
| 29 | HumanaHUM · Health Care | +67.3% | SGD 60.4B | SGD 503.10 | 2.63% up | 67% up | ||
| 30 | IlluminaILMN · Health Care | +62.0% | SGD 37.6B | SGD 248.74 | 3.90% down | 62% up | ||
| 31 | PACS GroupPACS · Health Care | +56.5% | SGD 8.9B | SGD 56.33 | 1.49% up | 56% up | ||
| 32 | ExelixisEXEL · Health Care | +54.9% | SGD 20.3B | SGD 83.37 | 1.82% down | 55% up | ||
| 33 | RevvityRVTY · Health Care | +54.3% | SGD 20.9B | SGD 187.33 | 4.20% down | 54% up | ||
| 34 | HaemoneticsHAE · Health Care | +52.8% | SGD 7.1B | SGD 155.01 | 0.17% down | 53% up | ||
| 35 | Adaptive BiotechnologiesADPT · Health Care | +50.7% | SGD 5.8B | SGD 36.03 | 0.43% down | 51% up | ||
| 36 | Krystal BiotechKRYS · Health Care | +49.0% | SGD 11.8B | SGD 398.47 | 2.19% down | 49% up | ||
| 37 | TeleflexTFX · Health Care | +48.2% | SGD 8.3B | SGD 208.44 | 1.11% down | 48% up | ||
| 38 | West Pharmaceutical ServicesWST · Health Care | +46.3% | SGD 35.1B | SGD 503.49 | 1.61% down | 46% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | +45.2% | SGD 10.2B | SGD 156.61 | 2.11% down | 45% up | ||
| 40 | HeartflowHTFL · Health Care | +44.7% | SGD 5.3B | SGD 60.23 | 4.62% up | 45% up | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | +44.0% | SGD 7.4B | SGD 370.04 | 0.03% down | 44% up | ||
| 42 | ImmunovantIMVT · Health Care | +44.0% | SGD 8.5B | SGD 40.98 | 2.31% down | 44% up | ||
| 43 | Molina HealthcareMOH · Health Care | +43.6% | SGD 13.4B | SGD 255.92 | 2.43% down | 44% up | ||
| 44 | BiogenBIIB · Health Care | +41.0% | SGD 47.6B | SGD 321.97 | 1.00% up | 41% up | ||
| 45 | Becton, DickinsonBDX · Health Care | +40.4% | SGD 74.8B | SGD 274.49 | 0.05% up | 40% up | ||
| 46 | Travere TherapeuticsTVTX · Health Care | +39.2% | SGD 5.8B | SGD 60.63 | 2.69% down | 39% up | ||
| 47 | Labcorp HoldingsLH · Health Care | +38.9% | SGD 38.5B | SGD 473.60 | 0.47% down | 39% up | ||
| 48 | Baxter InternationalBAX · Health Care | +38.7% | SGD 16.9B | SGD 32.75 | 0.00% | 39% up | ||
| 49 | Guardant HealthGH · Health Care | +38.1% | SGD 25.5B | SGD 188.12 | 0.16% up | 38% up | ||
| 50 | Tenet HealthcareTHC · Health Care | +37.3% | SGD 27B | SGD 339.52 | 0.15% down | 37% up | ||
| 51 | Merck & CoMRK · Health Care | +35.9% | SGD 425.3B | SGD 172.50 | 0.69% up | 36% up | ||
| 52 | Quest DiagnosticsDGX · Health Care | +35.5% | SGD 36.7B | SGD 333.18 | 0.31% down | 35% up | ||
| 53 | Mirum PharmaceuticalsMIRM · Health Care | +34.6% | SGD 8.1B | SGD 124.01 | 0.65% up | 35% up | ||
| 54 | DexComDXCM · Health Care | +33.1% | SGD 38.2B | SGD 102.32 | 1.08% down | 33% up | ||
| 55 | Halozyme TherapeuticsHALO · Health Care | +32.3% | SGD 13.4B | SGD 117.84 | 1.82% down | 32% up | ||
| 56 | Gilead SciencesGILD · Health Care | +31.5% | SGD 266.3B | SGD 214.69 | 0.06% down | 31% up | ||
| 57 | BrukerBRKR · Health Care | +31.4% | SGD 11.1B | SGD 72.83 | 9.08% down | 31% up | ||
| 58 | AvantorAVTR · Health Care | +31.3% | SGD 13B | SGD 19.14 | 1.85% down | 31% up | ||
| 59 | Johnson & JohnsonJNJ · Health Care | +31.0% | SGD 839.9B | SGD 348.91 | 1.25% up | 31% up | ||
| 60 | DaVitaDVA · Health Care | +30.0% | SGD 13.1B | SGD 207.73 | 3.00% up | 30% up | ||
| 61 | Cardinal HealthCAH · Health Care | +30.0% | SGD 81.3B | SGD 351.92 | 0.17% up | 30% up | ||
| 62 | AmgenAMGN · Health Care | +30.0% | SGD 304B | SGD 561.98 | 0.15% down | 30% up | ||
| 63 | Eli LillyLLY · Health Care | +27.5% | SGD 1.55T | SGD 1,737.77 | 0.30% down | 28% up | ||
| 64 | Bristol-Myers SquibbBMY · Health Care | +26.1% | SGD 155B | SGD 75.85 | 0.79% up | 26% up | ||
| 65 | NateraNTRA · Health Care | +25.7% | SGD 51.1B | SGD 352.69 | 5.70% down | 26% up | ||
| 66 | Scholar Rock HoldingSRRK · Health Care | +25.3% | SGD 7.6B | SGD 62.09 | 4.45% down | 25% up | ||
| 67 | Belite BioBLTE · Health Care | +25.3% | SGD 6.7B | SGD 164.32 | 15.65% down | 25% up | ||
| 68 | ChemedCHE · Health Care | +24.8% | SGD 9.2B | SGD 707.68 | 0.50% down | 25% up | ||
| 69 | McKessonMCK · Health Care | +22.6% | SGD 159.3B | SGD 1,379.56 | 0.68% up | 23% up | ||
| 70 | Regeneron PharmaceuticalsREGN · Health Care | +22.2% | SGD 122.9B | SGD 1,187.69 | 0.19% down | 22% up | ||
| 71 | VaxcytePCVX · Health Care | +22.1% | SGD 11.3B | SGD 71.45 | 5.09% down | 22% up | ||
| 72 | Edwards LifesciencesEW · Health Care | +22.0% | SGD 75.5B | SGD 131.39 | 1.95% down | 22% up | ||
| 73 | Vertex PharmaceuticalsVRTX · Health Care | +22.0% | SGD 168.4B | SGD 664.38 | 1.08% down | 22% up | ||
| 74 | Elevance HealthELV · Health Care | +21.3% | SGD 109.9B | SGD 508.88 | 1.11% up | 21% up | ||
| 75 | AbbVieABBV · Health Care | +20.0% | SGD 652.6B | SGD 369.20 | 0.94% up | 20% up | ||
| 76 | Elanco Animal HealthELAN · Health Care | +18.2% | SGD 16.6B | SGD 33.20 | 2.09% down | 18% up | ||
| 77 | Bio-TechneTECH · Health Care | +18.2% | SGD 14.7B | SGD 93.74 | 0.04% down | 18% up | ||
| 78 | United TherapeuticsUTHR · Health Care | +17.7% | SGD 30.5B | SGD 715.60 | 0.78% down | 18% up | ||
| 79 | Mettler-Toledo InternationalMTD · Health Care | +17.4% | SGD 42.8B | SGD 2,150.28 | 2.27% down | 17% up | ||
| 80 | Thermo Fisher ScientificTMO · Health Care | +17.2% | SGD 320B | SGD 863.71 | 2.79% down | 17% up | ||
| 81 | Bio-Rad LaboratoriesBIO · Health Care | +16.0% | SGD 12.5B | SGD 462.98 | 2.34% down | 16% up | ||
| 82 | Agilent TechnologiesA · Health Care | +15.9% | SGD 62B | SGD 219.79 | 2.83% down | 16% up | ||
| 83 | WatersWAT · Health Care | +15.9% | SGD 111.7B | SGD 568.18 | 3.51% down | 16% up | ||
| 84 | Encompass HealthEHC · Health Care | +15.7% | SGD 16.9B | SGD 172.41 | 1.04% up | 16% up | ||
| 85 | Henry ScheinHSIC · Health Care | +15.5% | SGD 11.9B | SGD 107.74 | 1.51% down | 16% up | ||
| 86 | Rhythm PharmaceuticalsRYTM · Health Care | +14.8% | SGD 10B | SGD 144.94 | 3.80% down | 15% up | ||
| 87 | BridgeBio PharmaBBIO · Health Care | +14.8% | SGD 19.1B | SGD 98.08 | 2.75% down | 15% up | ||
| 88 | IncyteINCY · Health Care | +13.5% | SGD 30.1B | SGD 147.87 | 1.07% down | 14% up | ||
| 89 | MSA SafetyMSA · Health Care | +13.1% | SGD 8.4B | SGD 219.34 | 3.52% down | 13% up | ||
| 90 | BioMarin PharmaceuticalBMRN · Health Care | +12.3% | SGD 15.1B | SGD 77.93 | 1.64% down | 12% up | ||
| 91 | GRAILGRAL · Health Care | +12.1% | SGD 5.8B | SGD 128.03 | 5.33% down | 12% up | ||
| 92 | Align TechnologyALGN · Health Care | +12.0% | SGD 14.1B | SGD 200.17 | 2.82% down | 12% up | ||
| 93 | IQVIA HoldingsIQV · Health Care | +11.4% | SGD 52.3B | SGD 317.11 | 1.89% down | 11% up | ||
| 94 | PenumbraPEN · Health Care | +10.9% | SGD 16.2B | SGD 411.66 | 0.28% down | 11% up | ||
| 95 | Neurocrine BiosciencesNBIX · Health Care | +10.4% | SGD 19.7B | SGD 194.24 | 3.84% down | 10% up | ||
| 96 | Zimmer Biomet HoldingsZBH · Health Care | +10.1% | SGD 24.7B | SGD 130.42 | 0.36% down | 10% up | ||
| 97 | PfizerPFE · Health Care | +9.98% | SGD 201.5B | SGD 35.35 | 0.51% down | 10% up | ||
| 98 | Arrowhead PharmaceuticalsARWR · Health Care | +7.91% | SGD 7.5B | SGD 53.37 | 5.22% down | 8% up | ||
| 99 | Medpace HoldingsMEDP · Health Care | +7.12% | SGD 22B | SGD 787.60 | 3.70% down | 7% up | ||
| 100 | GE HealthCare TechnologiesGEHC · Health Care | +7.12% | SGD 47B | SGD 104.03 | 1.53% down | 7% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2900 SGD).
Questions and answers
Which health care companies in the United States rank first by one-year price change?
Moderna (+740%), Erasca (+387%) and Kodiak Sciences (+371%) are the top three of the 140 health care companies in the United States ranked by one-year price change as of 21 Nov 2026, 06:02 UTC.
How many health care companies in the United States are in this ranking?
140 are ranked by one-year price change.
What are these health care companies in the United States worth together?
The 140 health care companies in the United States ranked by one-year price change have a combined market value of SGD 9.42T as of 21 Nov 2026, 06:02 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies in the United States by one-year price change”, data as of 21 November 2026. https://funkfolio.com/companies/sector/health-care?country=united-states&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.